Stéphane Lanthier

741 citations

16 papers · 548 indexed · h-index 13

Impact in

Genetics top 10%
- Virus-based gene therapy research
Molecular Biology
- Viral Infectious Diseases and Gene Expression in Insects
- Protein purification and stability
- CRISPR and Genetic Engineering
- RNA Interference and Gene Delivery

Papers in ⓘ

Molecular Biology 13
- Viral Infectious Diseases and Gene Expression in Insects 13
- Protein purification and stability 1
Genetics 13
- Virus-based gene therapy research 13
- Animal Genetics and Reproduction 2

Co-authors: Amine Kamen (12 shared papers)Sven Ansorge (7 shared papers)Olivier Henry (3 shared papers)Julia Transfiguracion (3 shared papers)Yves Durocher (1 shared paper)Bernard Massie (2 shared papers)Mark W. Johnson (2 shared papers)Danielle Jacob (3 shared papers)
Journals: Vaccine (4 papers)Biotechnology and Bioengineering (2 papers)Molecular Therapy (1 paper)Biochemical Engineering Journal (1 paper)Vaccines (1 paper)
Partner nations: Canada United States Germany

In The Last Decade

Stéphane Lanthier

16 papers receiving 533 citations

Peers

Countries citing papers authored by Stéphane Lanthier

Since Specialization

Citations

This map shows the geographic impact of Stéphane Lanthier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stéphane Lanthier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stéphane Lanthier more than expected).

Fields of papers citing papers by Stéphane Lanthier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stéphane Lanthier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stéphane Lanthier. The network helps show where Stéphane Lanthier may publish in the future.

Co-authors

The 25 scholars most cited alongside Stéphane Lanthier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Stéphane Lanthier Line = papers co-authored together Stéphane Lanthier links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work
1	Development of a scalable process for high‐yield lentiviral vector production by transient transfection of HEK293 suspension cultures The Journal of Gene Medicine ·Sven Ansorge, Stéphane Lanthier, Julia Transfiguracion, Yves Durocher, Olivier Henry, Amine Kamen	2009	114
2	Scalable Lentiviral Vector Production Using Stable HEK293SF Producer Cell Lines Human Gene Therapy Methods ·Aziza Manceur, Howard S. Kim, Vanja Misic, Nadejda Andreev, July Dorion-Thibaudeau, Stéphane Lanthier, Alice Bernier, Sonia Tremblay, Anne-Marie Gélinas, Sophie Broussau, Rénald Gilbert, Sven Ansorge	2017	83
3	Metabolic and Kinetic analyses of influenza production in perfusion HEK293 cell culture BMC Biotechnology ·Emma Petiot, Danielle Jacob, Stéphane Lanthier, Verena Lohr, Sven Ansorge, Amine Kamen	2011	60
4	Acoustic cell filter: a proven cell retention technology for perfusion of animal cell cultures Biotechnology Advances ·Irfan Z Shirgaonkar, Stéphane Lanthier, Amine Kamen	2004	47
5	Use of the Centritech Lab Centrifuge for Perfusion Culture of Hybridoma Cells in Protein‐Free Medium Biotechnology Progress ·Mark W. Johnson, Stéphane Lanthier, Bernard Massie, Gilles Lefèbvre, Amine Kamen	1996	43
6	Understanding factors that limit the productivity of suspension-based perfusion cultures operated at high medium renewal rates Biotechnology and Bioengineering ·Sylvain Mercille, Mark W. Johnson, Stéphane Lanthier, Amine Kamen, Bernard Massie	2000	40
7	Process optimization and scale-up for production of rabies vaccine live adenovirus vector (AdRG1.3) Vaccine ·Chun Fang Shen, Stéphane Lanthier, Danielle Jacob, Johnny Montes, Alex Beath, A. Beresford, Amine Kamen	2011	29
8	Process intensification for high yield production of influenza H1N1 Gag virus-like particles using an inducible HEK-293 stable cell line Vaccine ·Alina Venereo-Sánchez, Mélanie Simoneau, Stéphane Lanthier, Parminder S. Chahal, Lucie Bourget, Sven Ansorge, Rénald Gilbert, Olivier Henry, Amine Kamen	2017	28
9	Production of rVSV-ZEBOV in serum-free suspension culture of HEK 293SF cells Vaccine ·Jean‐François Gélinas, Hiva Azizi, Sascha Kießlich, Stéphane Lanthier, Jannie Perdersen, Parminder S. Chahal, Sven Ansorge, Gary Kobinger, Rénald Gilbert, Amine Kamen	2019	26
10	High cell density fed batch and perfusion processes for stable non‐viral expression of secreted alkaline phosphatase (SEAP) using insect cells: Comparison to a batch Sf‐9‐BEV system Biotechnology and Bioengineering ·Barbara Jardin, Johnny Montes, Stéphane Lanthier, Rosa Tran, Cynthia B. Elias	2006	22
11	Monitoring lentiviral vector production kinetics using online permittivity measurements Biochemical Engineering Journal ·Sven Ansorge, Stéphane Lanthier, Julia Transfiguracion, Olivier Henry, Amine Kamen	2011	21
12	Optimization and scale-up of cell culture and purification processes for production of an adenovirus-vectored tuberculosis vaccine candidate Vaccine ·Chun Fang Shen, Danielle Jacob, Tao Zhu, Alice Bernier, Zhongqi Shao, Xue‐Feng Yu, Mehul D. Patel, Stéphane Lanthier, Amine Kamen	2016	15
13	Rapid In-Process Monitoring of Lentiviral Vector Particles by High-Performance Liquid Chromatography Molecular Therapy — Methods & Clinical Development ·Julia Transfiguracion, Michelle Yen Tran, Stéphane Lanthier, Sonia Tremblay, Nathalie Coulombe, Mauro Acchione, Amine Kamen	2020	15
14	292. Towards Large-Scale Manufacturing of Adeno-Associated Virus by Transient Transfection of HEK293 Suspension Cells in a Stirred Tank Bioreactor Using Serum-Free Medium Molecular Therapy ·Parminder S. Chahal, Érica Alessandra Schulze, Alice Bernier, Stéphane Lanthier, Nathalie Coulombe, Amine Kamen, Rénald Gilbert	2016	3
15	Optimization of Culture Media and Feeding Strategy for High Titer Production of an Adenoviral Vector in HEK 293 Fed-Batch Culture Vaccines ·Chun Fang Shen, Anja Rodenbrock, Stéphane Lanthier, Elodie Burney, Martin Loignon	2024	1
16	Towards continuous bioprocessing of lentiviral vectors Sven Ansorge, Maurizio Cattaneo, Anja Rodenbrock, July Dorion-Thibaudeau, Sonia Tremblay, Aziza Manceur, Louis-Patrick Gagnon, Krishna Raj Tiwari, Rénald Gilbert, Stéphane Lanthier	2019	1

About Stéphane Lanthier

Stéphane Lanthier is a scholar working on Molecular Biology, Genetics, Infectious Diseases, Oncology and Biotechnology, having authored 16 papers that have together received 548 indexed citations. Recurring topics across this work include Virus-based gene therapy research (13 papers), Viral Infectious Diseases and Gene Expression in Insects (13 papers), CAR-T cell therapy research (5 papers), Viral gastroenteritis research and epidemiology (4 papers), Animal Genetics and Reproduction (2 papers), Protein purification and stability (1 paper), Cancer Research and Treatments (1 paper) and Tuberculosis Research and Epidemiology (1 paper). The work is most often cited by research in Genetics (294 citations), Molecular Biology (428 citations), Infectious Diseases (112 citations), Biotechnology (44 citations) and Oncology (108 citations). Stéphane Lanthier has collaborated with scholars based in Canada, United States and Germany. Frequent co-authors include Amine Kamen, Sven Ansorge, Olivier Henry, Julia Transfiguracion, Yves Durocher, Bernard Massie, Mark W. Johnson, Danielle Jacob, Emma Petiot and Verena Lohr. Their work appears in journals such as Vaccine, Biotechnology and Bioengineering, Molecular Therapy, Biochemical Engineering Journal and Vaccines.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact